VEON vs. USM, SPOK, SIDU, SYTA, TIGO, SKM, TMUS, CHT, VOD, and TU
Should you be buying VEON stock or one of its competitors? The main competitors of VEON include United States Cellular (USM), Spok (SPOK), Sidus Space (SIDU), Siyata Mobile (SYTA), Millicom International Cellular (TIGO), SK Telecom (SKM), T-Mobile US (TMUS), Chunghwa Telecom (CHT), Vodafone Group Public (VOD), and TELUS (TU). These companies are all part of the "radiotelephone communication" industry.
United States Cellular (NYSE:USM) and VEON (NASDAQ:VEON) are both computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, dividends, valuation, institutional ownership, earnings, media sentiment, profitability and risk.
In the previous week, United States Cellular had 18 more articles in the media than VEON. MarketBeat recorded 30 mentions for United States Cellular and 12 mentions for VEON. VEON's average media sentiment score of 0.73 beat United States Cellular's score of 0.27 indicating that United States Cellular is being referred to more favorably in the media.
United States Cellular has a beta of 0.45, indicating that its share price is 55% less volatile than the S&P 500. Comparatively, VEON has a beta of 1.59, indicating that its share price is 59% more volatile than the S&P 500.
VEON received 164 more outperform votes than United States Cellular when rated by MarketBeat users. Likewise, 57.80% of users gave VEON an outperform vote while only 56.47% of users gave United States Cellular an outperform vote.
VEON has a net margin of 37.89% compared to VEON's net margin of 1.55%. United States Cellular's return on equity of 102.03% beat VEON's return on equity.
United States Cellular presently has a consensus price target of $58.75, suggesting a potential upside of 5.93%. Given VEON's higher possible upside, equities analysts plainly believe United States Cellular is more favorable than VEON.
United States Cellular has higher revenue and earnings than VEON.
18.0% of United States Cellular shares are owned by institutional investors. Comparatively, 21.3% of VEON shares are owned by institutional investors. 1.0% of United States Cellular shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Summary
United States Cellular and VEON tied by winning 8 of the 16 factors compared between the two stocks.
Get VEON News Delivered to You Automatically
Sign up to receive the latest news and ratings for VEON and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding VEON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
